Literature DB >> 33489157

Granulocyte-colony stimulating factor-producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review.

Shintaro Shiba1,2, Takahiro Oike1,2, Ken Ando1, Yuya Yoshimoto3, Yoshiyasu Takayama4, Tatsuya Ohno1.   

Abstract

Granulocyte-colony stimulating factor-producing uterine cervical cancer is a rare aggressive disease, which may be genetically distinct from other uterine cervical cancers.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  granulocyte‐colony stimulating factor; radiotherapy; somatic mutations; uterine cervical cancer

Year:  2020        PMID: 33489157      PMCID: PMC7812995          DOI: 10.1002/ccr3.3495

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


  29 in total

1.  A human lung cancer xenograft producing granulocyte-colony stimulating factor and parathyroid hormone-related protein.

Authors:  Y Oshika; M Nakamura; H Hatanaka; Y Abe; T Tokunaga; Y Ohnishi; H Kijima; H Yamazaki; N Tamaoki; Y Ueyama
Journal:  Oncol Rep       Date:  1998 Mar-Apr       Impact factor: 3.906

2.  Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue.

Authors:  S Asano; A Urabe; T Okabe; N Sato; Y Kondo
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

3.  Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates.

Authors:  Joseph P Connor
Journal:  Gynecol Oncol       Date:  2006-06-16       Impact factor: 5.482

4.  The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix.

Authors:  Seiji Mabuchi; Yuri Matsumoto; Eiichi Morii; Kenichirou Morishige; Tadashi Kimura
Journal:  Int J Gynecol Pathol       Date:  2010-09       Impact factor: 2.762

5.  A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

Authors:  Yiqun Zhang; Patrick Kwok-Shing Ng; Melanie Kucherlapati; Fengju Chen; Yuexin Liu; Yiu Huen Tsang; Guillermo de Velasco; Kang Jin Jeong; Rehan Akbani; Angela Hadjipanayis; Angeliki Pantazi; Christopher A Bristow; Eunjung Lee; Harshad S Mahadeshwar; Jiabin Tang; Jianhua Zhang; Lixing Yang; Sahil Seth; Semin Lee; Xiaojia Ren; Xingzhi Song; Huandong Sun; Jonathan Seidman; Lovelace J Luquette; Ruibin Xi; Lynda Chin; Alexei Protopopov; Thomas F Westbrook; Carl Simon Shelley; Toni K Choueiri; Michael Ittmann; Carter Van Waes; John N Weinstein; Han Liang; Elizabeth P Henske; Andrew K Godwin; Peter J Park; Raju Kucherlapati; Kenneth L Scott; Gordon B Mills; David J Kwiatkowski; Chad J Creighton
Journal:  Cancer Cell       Date:  2017-05-18       Impact factor: 31.743

6.  Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor.

Authors:  Kaei Nasu; Chieko Inoue; Noriyuki Takai; Kenji Kashima; Isao Miyakawa
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

7.  Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.

Authors:  Alina Sturdza; Richard Pötter; Lars Ulrik Fokdal; Christine Haie-Meder; Li Tee Tan; Renaud Mazeron; Primoz Petric; Barbara Šegedin; Ina Maria Jurgenliemk-Schulz; Christel Nomden; Charles Gillham; Orla McArdle; Erik Van Limbergen; Hilde Janssen; Peter Hoskin; Gerry Lowe; Ekkasit Tharavichitkul; Elena Villafranca; Umesh Mahantshetty; Petra Georg; Kathrin Kirchheiner; Christian Kirisits; Kari Tanderup; Jacob Christian Lindegaard
Journal:  Radiother Oncol       Date:  2016-04-29       Impact factor: 6.280

8.  Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.

Authors:  Sokbom Kang; Hy-Sook Kim; Sang Soo Seo; Sang-Yoon Park; David Sidransky; Seung Myung Dong
Journal:  Gynecol Oncol       Date:  2007-03-13       Impact factor: 5.482

9.  Integrated genomic and molecular characterization of cervical cancer.

Authors: 
Journal:  Nature       Date:  2017-01-23       Impact factor: 49.962

10.  Purification and characterization of human granulocyte colony-stimulating factor (G-CSF).

Authors:  H Nomura; I Imazeki; M Oheda; N Kubota; M Tamura; M Ono; Y Ueyama; S Asano
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.